Robbins Andrew R 4
4 · Cogent Biosciences, Inc. · Filed Dec 9, 2020
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-12-07+456,693→ 456,693 totalExercise: $12.76Exp: 2030-12-07→ Common Stock (456,693 underlying)
Footnotes (1)
- [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.